Spyre Therapeutics, Inc. (SYRE)

43.46 -0.72 (-1.64%) USD  |  NASDAQ  |  Feb 24, 16:00
43.46 0.00 (0.00%) After-Hours: 20:00
More

Spyre Therapeutics Long Term Deferred Tax Assets (Quarterly)

Long Term Deferred Tax Assets (Quarterly) Chart

View Long Term Deferred Tax Assets (Quarterly) for SYRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Long Term Deferred Tax Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Long Term Deferred Tax Assets (Quarterly) Range, Past 5 Years

View Long Term Deferred Tax Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Long Term Deferred Tax Assets (Quarterly) Benchmarks

View Long Term Deferred Tax Assets (Quarterly) Benchmarks
Start Trial
PTC Therapeutics, Inc. --
Tandem Diabetes Care, Inc. --
ACADIA Pharmaceuticals, Inc. --
Alnylam Pharmaceuticals, Inc. Upgrade
Savara, Inc. --